These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 26668752)
1. Plant-based vaccines for animals and humans: recent advances in technology and clinical trials. Takeyama N; Kiyono H; Yuki Y Ther Adv Vaccines; 2015 Sep; 3(5-6):139-54. PubMed ID: 26668752 [TBL] [Abstract][Full Text] [Related]
2. History of regulatory requirements for poultry biologics in the United States, 1970s to 1990s. Espeseth DA; Lasher H Avian Dis; 2013 Jun; 57(2):167-71. PubMed ID: 24689169 [TBL] [Abstract][Full Text] [Related]
3. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal. Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502 [TBL] [Abstract][Full Text] [Related]
4. Plant-made vaccines against viral diseases in humans and farm animals. Su H; van Eerde A; Rimstad E; Bock R; Branza-Nichita N; Yakovlev IA; Clarke JL Front Plant Sci; 2023; 14():1170815. PubMed ID: 37056490 [TBL] [Abstract][Full Text] [Related]
5. Engineering DNA vaccines against infectious diseases. Lee J; Arun Kumar S; Jhan YY; Bishop CJ Acta Biomater; 2018 Oct; 80():31-47. PubMed ID: 30172933 [TBL] [Abstract][Full Text] [Related]
6. Licensing Requirements for Poultry Veterinary Biologics in the United States. Schrader JS; Smith HE Avian Dis; 2024 Jan; 67(4):467-473. PubMed ID: 38300665 [TBL] [Abstract][Full Text] [Related]
7. Recent Progress on Vaccines Produced in Transgenic Plants. Gaobotse G; Venkataraman S; Mmereke KM; Moustafa K; Hefferon K; Makhzoum A Vaccines (Basel); 2022 Nov; 10(11):. PubMed ID: 36366370 [TBL] [Abstract][Full Text] [Related]
8. Use of plant viruses and virus-like particles for the creation of novel vaccines. Balke I; Zeltins A Adv Drug Deliv Rev; 2019 May; 145():119-129. PubMed ID: 30172923 [TBL] [Abstract][Full Text] [Related]
10. Farming of Plant-Based Veterinary Vaccines and Their Applications for Disease Prevention in Animals. Liew PS; Hair-Bejo M Adv Virol; 2015; 2015():936940. PubMed ID: 26351454 [TBL] [Abstract][Full Text] [Related]
11. From gene to harvest: insights into upstream process development for the GMP production of a monoclonal antibody in transgenic tobacco plants. Sack M; Rademacher T; Spiegel H; Boes A; Hellwig S; Drossard J; Stoger E; Fischer R Plant Biotechnol J; 2015 Oct; 13(8):1094-105. PubMed ID: 26214282 [TBL] [Abstract][Full Text] [Related]
15. Regulations for vaccines against emerging infections and agrobioterrorism in the United States of America. Elsken LA; Carr MY; Frana TS; Brake DA; Garland T; Smith K; Foley PL Rev Sci Tech; 2007 Aug; 26(2):429-41. PubMed ID: 17892163 [TBL] [Abstract][Full Text] [Related]
16. Commercialization of veterinary viral vaccines. Flore PH Anim Health Res Rev; 2004 Dec; 5(2):239-42. PubMed ID: 15984331 [TBL] [Abstract][Full Text] [Related]
18. Plant-made vaccines for humans and animals. Rybicki EP Plant Biotechnol J; 2010 Jun; 8(5):620-37. PubMed ID: 20233333 [TBL] [Abstract][Full Text] [Related]
19. Regulatory considerations for emergency use of non-USDA licensed vaccines in the United States. Hill RE; Foley PL; Carr MY; Elsken LA; Gatewood DM; Ludemann LR; Wilbur LA Dev Biol (Basel); 2003; 114():31-52. PubMed ID: 14677675 [TBL] [Abstract][Full Text] [Related]